Zydus Worldwide DMCC, a subsidiary of the company, has signed a definitive agreement, through its wholly-owned acquisition arm Zara Merger Sub Inc, with Assertio Holdings Inc to acquire all outstanding shares of Assertio for USD 23.50 per share in cash, Zydus Lifesciences Ltd said in a statement. Ahmedabad-based Zydus Lifesciences on Wednesday said it will acquire US-based pharma firm Assertio Holdings for a total consideration of USD 166.4 million (approximately Rs 1,590 crore). Zydus Worldwide DMCC, a subsidiary of the company, has signed a definitive agreement, through its wholly-owned acquisition arm Zara Merger Sub Inc, with Assertio Holdings Inc to acquire all outstanding shares of Assertio for USD 23.50 per share in cash, Zydus Lifesciences Ltd said in a statement. A statement from Zydus on Wednesday said, “The acquisition provides Zydus with an established US specialty oncology commercial platform, anchored by Assertio’s presence in oncology supportive care.…